Anti-platelet drugs and outcome in severe infection: Clinical impact and underlying mechanisms

Author： Winning Johannes   Reichel Julia   Eisenhut Yvonne   Hamacher Jurg   Kohl Matthias   Deigner Hans Peter   Claus Ralf   Bauer Michael   Losche Wolfgang  

Publisher： Informa Healthcare

ISSN： 1369-1635

Source： Platelets, Vol.20, Iss.1, 2009-02, pp. : 50-57

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Platelet Resistance to Antiplatelet Drugs

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 4, Iss. 2, 2009-06 ,pp. : 98-108

Bentham Science Publishers

Access to resources Recommend Favorite

Influence of genetic polymorphisms on platelet function, response to antiplatelet drugs and clinical outcomes in patients with coronary artery disease

By Tantry Udaya S   Jeong Young-Hoon   Navarese Eliano P   Kubica Jacek   Gurbel Paul A  

Expert Review of Cardiovascular Therapy, Vol. 11, Iss. 4, 2013-04 ,pp. : 447-462

Informa Healthcare

Access to resources Recommend Favorite

Clinical Perspectives on the Role of Anti-Platelet and Statin Therapy in Patients with Vascular Diseases

By  

Current Vascular Pharmacology, Vol. 1, Iss. 3, 2003-10 ,pp. : 329-333

Bentham Science Publishers

Access to resources Recommend Favorite

Monitoring of the Antiplatelet Drugs Effect in Patients with Coronary Artery Disease: What is the Real Clinical Impact?

By  

Current Vascular Pharmacology, Vol. 5, Iss. 4, 2007-01 ,pp. : 293-301

Bentham Science Publishers

Access to resources Recommend Favorite

A paradigm shift in anti-platelet therapy?

By Bonello L.   Barragan P.   Paganelli F.  

Platelets, Vol. 19, Iss. 8, 2008-12 ,pp. : 562-564

Informa Healthcare

Access to resources Recommend Favorite